DMTR Deepmatter Group Plc

TIDMCRON

Cronin Group PLC

31 January 2017

31 January 2017

Cronin Group Plc

("Cronin" or the "Company")

Presentation at Healthcare Conference

Between the 9(th) and 12(th) January 2017 Professor Lee Cronin, Founding Scientific Director, will be attending the 35th Annual J.P. Morgan Healthcare Conference and at which he will be presenting the Company's pathway to its first commercial product.

During 2017 Cronin Group intends to release prototype and beta versions of its DigitialGlassware(TM) product, which it anticipates will undergo testing and development with a number of collaboration partners. Early product releases of DigitalGlassware(TM) will be a low-cost, easy to use chemical telemetry product designed to enable the first digitization of chemistry in commercial and academic research laboratories. Eventually the DigitalGlassware(TM) platform is envisaged to have a range of commercial applications in various target markets, including Healthcare.

Cronin Group's ultimate vision is to commercialise the Chemputer(TM), an autonomous universal digital synthesis engine, which intends to open up chemistry to a wider user-base via digitization. This will allow chemical synthesis to be flexible and widely accessible irrespective of access to physical infrastructure and chemical knowledge.

ENDS

 
 Contacts: 
 
 Cronin Group Plc                www.croningroupplc.com 
 James Ede-Golightly, Chairman   T: 01481 701 564 
 
 WH Ireland Limited              www.wh-ireland.co.uk 
 Mike Coe / Ed Allsopp           T: 0117 945 3470 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRASDIFESFWSESF

(END) Dow Jones Newswires

January 31, 2017 02:01 ET (07:01 GMT)

Deepmatter (LSE:DMTR)
Historical Stock Chart
From Apr 2024 to May 2024

Deepmatter (LSE:DMTR)
Historical Stock Chart
From May 2023 to May 2024